Back to search

Article

Elongin BC complex negatively regulates AXL and marks a differentiated phenotype in melanoma

2022-07-29

Abstract excerpt

<title>Abstract</title> <p>High expression of the receptor tyrosine kinase AXL is implicated in epithelial-to-mesenchymal transition, cancer progression and therapy resistance. For example, AXL is abundant in BRAF mutant melanomas progressing on targeted BRAF/MEK inhibition. Therefore, AXL is thought to represent an attractive therapeutic target. This notwithstanding, little is known about the mechanisms governin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
171f1c1e-2386-5c89-ae1d-0b9832ab3b1b
DOI
10.21203/rs.3.rs-1808665/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Elongin BC complex negatively regulates AXL and marks a differentiated phenotype in melanomaDOI 10.21203/rs.3.rs-1808665/v1
Select a neighboring publication to make it the new centre.